Telehealth Technologies Stethoscope Receives Patent Approval From Canada

Share Article

Already FDA approved, ISO 13485 certified and patented in the United States, RNK Products, Inc. now receives patent approval from Canada for its telephonic stethoscope.

As the growth in telemedicine continues to rise, RNK Products, Inc. and its Telehealth Technologies line of telephonic stethoscopes are still the most widely used in the world. Already FDA approved, ISO 13485 certified and patented in the United States, RNK Products, Inc. now receives patent approval from Canada.

“Remote auscultation is a critical component of a telemedicine initiative”, says C. R. (Rich) Abbruscato, CEO of RNK Products and designer of telephonic stethoscopes. Whether in a rural hospital or an embassy in a foreign country, the Telehealth Technologies telephonic stethoscopes offer convenience while still delivering the sound quality physicians expect.

The Canadian patent approval adds to RNK’s consortium of patents and helps secure their lead in the telephonic stethoscope space. “We are excited to have received approval from Canada and we look forward to adding value to future telehealth initiatives across the globe”, says Rich Abbruscato.

ABOUT RNK PRODUCTS, INC.
Founded in 2003, RNK Products, Inc. specializes in electronic and telephonic stethoscopes, under both its own label Telehealth Technologies, and under private labels used by our Value-Added Resellers. RNK offers a range of stethoscopes to fit any institutional or home telemedicine program. Our longevity in telemedicine has been a tremendous asset to the organization by delivering high quality, high performance products that stand the test of time, along with fulfilling the technology needs of today and tomorrow.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole Stefurak
Visit website